Table 8.
Effect of adrenergic receptor activation on IPSC amplitude with and without Dex pre-treatment.
| Control (pA) | NE/Agonist (pA) | NE/Agonist+Dex (pA) | F | n | p | Con vs. NE/PHE | Con vs. NE/PHE+Dex | NE/PHE vs. NE/PHE+Dex | |
|---|---|---|---|---|---|---|---|---|---|
| NE+Dex | 57.90 ± 9.34 | 80.61 ± 11.57 | 68.58 ± 13.56 | 7.11 | 11 | 0.007∗ | ∗∗ | NS | NS |
| PHE+Dex | 57.09 ± 4.02 | 60.66 ± 9.19 | n/a | t = 0.48 | df = 9 | 0.64 | NS | n/a | n/a |
| Control (pA) | Dex (pA) | Dex+NE/agonist (pA) | F | n | p | Con vs. Dex | Con vs. Dex+NE/PHE | Dex vs. Dex+NE/PHE | |
| Dex+NE | 49.38 ± 2.52 | 49.60 ± 4.04 | 73.63 ± 8.72 | 13.44 | 15 | 0.001∗ | NS | ∗∗ | ∗∗ |
| Dex+ PHE | 52.75 ± 3.74 | 51.55 ± 4.19 | 59.62 ± 5.10 | 6.14 | 15 | 0.01∗ | NS | ∗ | ∗ |
∗p < 0.05, ∗∗p < 0.01.